Emergent BioSolutions has acquired PaxVax Inc. Emergent BioSolutions is a global specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Emergent's mission is simple - to protect and enhance life
View Top Employees from PaxVax, Inc.| Website | http://www.paxvax.com |
| Revenue | $17.5 million |
| Funding | $247.5 million |
| Employees | 30 (26 on RocketReach) |
| Founded | 2007 |
| Address | 900 Veterans Blvd Suite 500, Redwood City, California 94063, US |
| Phone | (650) 847-1075 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+27 more
(view full list)
|
| Industry | Pharmaceuticals, Biotechnology Research, Drug Discovery, Viral Vaccines, Healthcare, Cholera, Drug Manufacturing & Research, HIV, Biotechnology, Adenovirus, Influenza, Vivotif® oral typhoid vaccine |
| Web Rank | 7 Million |
| Keywords | Paxvax, Paxvax, Inc, Chikungunya Vaccine, Paxvax Internship, Tyhpoid Manufactuer |
| Competitors | ChemoCentryx, Genocea, VBI Vaccines Inc., VGX Pharmaceuticals |
| SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular PaxVax, Inc. employee's phone or email?
PaxVax, Inc. Questions
The PaxVax, Inc. annual revenue was $17.5 million in 2023.
26 people are employed at PaxVax, Inc..
PaxVax, Inc. is based in Redwood City, California.
The NAICS codes for PaxVax, Inc. are [3254, 325, 32541, 32].
The SIC codes for PaxVax, Inc. are [28, 2834, 283].
Top PaxVax, Inc. Employees
-
25+
-
25+
-
ViewPamela Green
Vice President,finance, and Controller at PaxVax, Inc.
San Francisco, California, United States35+ -
1
-
21
-
34
-
2
-
Related Companies
